Ligand ID: FMM Drugbank ID: DB01259(Lapatinib) Indication:Indicated in combination with capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress the human epidermal receptor type 2 (HER2) protein and who have received prior therapy including an anthracycline, a taxane, and trastuzuma. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 148LEU A 89LEU A 32GLY A 15LEU A 27 | 1.69A | 20.18 | NoneNoneNoneDMS A 403 (-3.8A)None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 146CYH A 38LEU A 87LEU A 27THR A 26 | 1.70A | 22.98 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 9 | LEU A 32VAL A 35LYS A 88LEU A 87LEU A 30 | 1.76A | 22.98 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 204THR A 199GLY A 275LEU A 272LEU A 242 | 1.64A | 20.18 | None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 29CYH A 38LEU A 87LEU A 27THR A 25 | 1.75A | 22.98 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 9 | LEU A 75VAL A 68LEU A 27MET A 17LEU A 87 | 1.67A | 22.98 | None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ALA A 129LEU A 282THR A 292ASP A 295PHE A 294 | 1.45A | 22.98 | NoneNoneNoneDMS A 402 ( 4.5A)None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 202THR A 292GLY A 251LEU A 253PHE A 3 | 1.75A | 20.18 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 86MET A 130LEU A 27GLY A 29PHE A 112 | 1.38A | 20.18 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6lxt | SPIKE PROTEIN S2 (SARS-CoV-2) | 5 / 12 | VAL E1164ALA F 972LEU F 977GLY E1167LEU D 977 | 1.30A | 17.85 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | ALA A 206LEU A 268LEU A 253GLY A 251PHE A 230 | 1.67A | 21.45 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU A 87VAL A 86LEU A 32LEU A 30LEU A 89 | 1.71A | 22.47 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU A 75VAL A 68LEU A 27MET A 17LEU A 87 | 1.66A | 22.47 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 296ALA A 210LEU A 208GLY A 302THR A 257 | 1.78A | 21.45 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 202THR A 292GLY A 251LEU A 253PHE A 3 | 1.74A | 21.45 | None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 146CYH A 38LEU A 87LEU A 27THR A 26 | 1.72A | 22.47 | None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 29CYH A 38LEU A 87LEU A 27THR A 25 | 1.74A | 22.47 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 148LEU A 89LEU A 32GLY A 15LEU A 27 | 1.71A | 21.45 | NoneNoneNoneDMS A 403 (-4.0A)None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | ALA A 206LEU A 268LEU A 253GLY A 251PHE A 230 | 1.70A | 21.45 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU A 87VAL A 86LEU A 32LEU A 30LEU A 89 | 1.78A | 22.40 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 148LEU A 89LEU A 32GLY A 15LEU A 27 | 1.70A | 21.45 | NoneNoneNoneDMS A 401 (-4.3A)None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU A 75VAL A 68LEU A 27MET A 17LEU A 87 | 1.68A | 22.40 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 296ALA A 210LEU A 208GLY A 302THR A 257 | 1.80A | 21.45 | None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 29CYH A 38LEU A 87LEU A 27THR A 25 | 1.77A | 22.40 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 202THR A 292GLY A 251LEU A 253PHE A 3 | 1.74A | 21.45 | None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 146CYH A 38LEU A 87LEU A 27THR A 26 | 1.67A | 22.40 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m17 | ACE2RECEPTOR BINDINGDOMAIN (Homosapiens;SARS-CoV-2) | 5 / 12 | ALA D 386MET D 376GLY F 504THR D 324PHE D 327 | 1.52A | 16.30 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 202THR A 292GLY A 251LEU A 253PHE A 3 | 1.70A | 21.17 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL D 202THR D 292GLY D 251LEU D 253PHE D 3 | 1.73A | 21.17 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL B 202THR B 292GLY B 251LEU B 253PHE B 3 | 1.75A | 21.17 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL B 202THR B 292GLY B 251LEU B 253PHE B 3 | 1.73A | 21.17 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU B 87VAL B 86LEU B 32LEU B 30LEU B 89 | 1.76A | 22.55 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL B 125ALA D 7GLY D 11LEU D 115PHE D 140 | 1.74A | 21.17 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU C 75VAL C 68LEU C 27MET C 17LEU C 87 | 1.64A | 22.55 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU C 287VAL C 204LEU C 242LEU C 271LEU C 250 | 1.78A | 22.55 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 296ALA A 210LEU A 208GLY A 302THR A 257 | 1.71A | 21.17 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ALA C 206LEU C 268LEU C 253GLY C 251PHE C 230 | 1.67A | 21.17 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ALA A 206LEU A 268LEU A 253GLY A 251PHE A 230 | 1.66A | 21.17 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU A 87VAL A 86LEU A 32LEU A 30LEU A 89 | 1.78A | 22.55 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 148LEU A 89LEU A 32GLY A 15LEU A 27 | 1.70A | 21.17 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL C 204THR C 199GLY C 275LEU C 272LEU C 242 | 1.75A | 21.17 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 18GLY A 146LEU A 27THR A 26LEU A 67 | 1.72A | 21.17 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL C 204THR C 199GLY C 275LEU C 272LEU C 242 | 1.70A | 21.17 | None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ALA C 129LEU C 282THR C 292ASP C 295PHE C 294 | 1.51A | 22.55 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL B 296ALA B 210LEU B 208GLY B 302THR B 257 | 1.71A | 21.17 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ALA B 206LEU B 268LEU B 253GLY B 251PHE B 230 | 1.64A | 21.17 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU D 75VAL D 68LEU D 27MET D 17LEU D 87 | 1.68A | 22.55 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL C 202THR C 292GLY C 251LEU C 253PHE C 3 | 1.72A | 21.17 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU B 75VAL B 68LEU B 27MET B 17LEU B 87 | 1.69A | 22.55 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU D 287VAL D 204LEU D 242LEU D 271LEU D 250 | 1.73A | 22.55 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL B 148LEU B 89LEU B 32GLY B 15LEU B 27 | 1.71A | 21.17 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 125ALA C 7GLY C 11LEU C 115PHE C 140 | 1.77A | 21.17 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU C 87VAL C 86LEU C 32LEU C 30LEU C 89 | 1.74A | 22.55 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU B 32VAL B 35LYS B 88LEU B 87LEU B 30 | 1.79A | 22.55 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU A 75VAL A 68LEU A 27MET A 17LEU A 87 | 1.71A | 22.55 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU D 87VAL D 86LEU D 32LEU D 30LEU D 89 | 1.76A | 22.55 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 204THR A 199GLY A 275LEU A 272LEU A 242 | 1.67A | 21.17 | None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ALA A 129LEU A 282THR A 292ASP A 295PHE A 294 | 1.58A | 22.55 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ALA A 206LEU A 268LEU A 253GLY A 251PHE A 230 | 1.69A | 21.17 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU A 87VAL A 86LEU A 32LEU A 30LEU A 89 | 1.74A | 22.55 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU A 75VAL A 68LEU A 27MET A 17LEU A 87 | 1.69A | 22.55 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU A 32VAL A 35LYS A 88LEU A 87LEU A 30 | 1.79A | 22.55 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 148LEU A 89LEU A 32GLY A 15LEU A 27 | 1.72A | 21.17 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 9 | LEU A 287VAL A 204LEU A 242LEU A 271LEU A 250 | 1.80A | 22.55 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 5 / 9 | LEU D 122CYH C 32LEU C 13LEU C 56LEU C 60 | 1.63A | 21.91 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | VAL B 115LEU A 270GLY A 345PHE A 396LEU B 122 | 1.75A | 19.58 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 9 | CYH A 464LEU A 316LEU A 245LEU A 460LEU A 241 | 1.72A | 15.28 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | VAL A 476MET A 629LEU A 630LEU A 638LEU A 308 | 1.59A | 16.24 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | ALA B 86LEU A 371THR B 84GLY A 510LEU A 514 | 1.79A | 19.58 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | VAL A 341LEU A 271LEU B 117GLY A 385THR B 124 | 1.58A | 16.24 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | VAL A 330ALA A 383LEU B 122LEU B 103LEU A 271 | 1.62A | 16.24 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | VAL A 174ALA A 176LEU A 178THR A 248LEU A 142 | 1.66A | 16.24 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 9 | LEU A 245LEU A 212LEU A 178LEU A 186LEU A 142 | 1.77A | 15.28 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL B 976GLY A 545LEU A 546THR A 573ASP A 571 | 1.30A | 13.33 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ALA A 522LEU A 518THR A 393GLY A 526PHE A 429 | 1.53A | 13.33 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 9 | LEU B 83VAL B 82LEU B 127LEU B 43LEU B 122 | 1.55A | NoneNHE B 203 (-4.9A)NoneNoneNone | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 9 | LEU A 83VAL A 82LEU A 127LEU A 43LEU A 122 | 1.54A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | LEU C 212ASP C 215ARG C 214LEU C 189THR C 208 | 1.46A | 14.15 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | LEU A 517THR A 430LEU A 425GLY A 413LEU B 984 | 1.42A | 13.43 | None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ALA A 570THR A 572GLY B 857ASP B 737PHE A 541 | 1.63A | 14.15 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 6 / 12 | ALA A 876LEU A 806LEU A 877GLY A 889THR A 883PHE A 797 | 1.75A | 13.43 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 9 | LEU A 83VAL A 82LEU A 127LEU A 43LEU A 122 | 1.53A | 24.71 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w41 | CR3022 FAB HEAVYCHAINSPIKE PROTEIN S1 (Homosapiens;SARS-CoV-2) | 5 / 12 | LEU C 387THR C 385GLY H 94THR H 31PHE C 377 | 1.53A | 19.15 | None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w4b | NSP9 (SARS-CoV-2) | 5 / 12 | ALA B 108THR B 110GLY A 101LEU A 89THR A 110 | 1.65A | 17.43 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w4h | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ALA B4324GLY A6875THR A6908ASP A6895LEU A6893 | 1.52A | 16.41 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w4h | NSP16 (SARS-CoV-2) | 5 / 9 | LEU A7052VAL A6859LEU A6883LEU A6924LEU A6852 | 1.47A | 20.22 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 9 | LEU A6883VAL A6882LEU A7042LEU B4298LEU A6848 | 1.55A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | ALA A6808GLY A7006CYH A7007LEU A6855THR A6854 | 1.75A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA A6877LEU A6883GLY B4323PHE A7048LEU A6887 | 1.75A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 9 | LEU A6834LYS A6844LEU A6848LEU B4298MET B4297 | 1.74A | NoneEDO A7103 (-3.6A)NoneNoneNone | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA B4324GLY A6875THR A6908ASP A6895LEU A6893 | 1.55A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA B4324GLY A6875THR A6908ASP A6895LEU A6893 | 1.50A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 9 | LEU A7052VAL A6859LEU A6883LEU A6924LEU A6852 | 1.44A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 18GLY A 146LEU A 27THR A 26LEU A 67 | 1.71A | NoneNoneX77 A 401 ( 3.9A)NoneNone | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 202THR A 292GLY A 251LEU A 253PHE A 3 | 1.73A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 148LEU A 89LEU A 32GLY A 15LEU A 27 | 1.72A | NoneNoneNoneNoneX77 A 401 ( 3.9A) | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 9 | LEU A 87VAL A 86LEU A 32LEU A 30LEU A 89 | 1.73A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ALA A 206LEU A 268LEU A 253GLY A 251PHE A 230 | 1.65A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 9 | LEU A 287VAL A 204LEU A 242LEU A 271LEU A 250 | 1.76A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 77ALA A 112LEU A 93LEU A 109LEU A 43 | 1.53A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 9 | LEU A 83VAL A 82LEU A 127LEU A 43LEU A 122 | 1.51A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | VAL B 77ALA B 112LEU B 93LEU B 109LEU B 43 | 1.53A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 9 | LEU B 83VAL B 82LEU B 127LEU B 43LEU B 122 | 1.55A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ALA A 38LEU A 93GLY A 51LEU A 53LEU A 83 | 1.79A | 19.42 | AMP A 201 ( 3.9A)NoneNoneNoneNone | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | VAL B 49ALA B 38LEU B 126GLY B 46LEU B 160 | 1.79A | NoneMES B 201 ( 3.4A)NoneNoneNone | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 9 | LEU C7052VAL C6859LEU C6883LEU C6924LEU C6852 | 1.50A | 19.03 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ALA B4324GLY A6875THR A6908ASP A6895LEU A6893 | 1.52A | 16.41 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 9 | LEU C6834LYS C6844LEU C6848LEU D4298MET D4297 | 1.75A | 19.03 | NoneFMT C7108 ( 4.0A)NoneNoneNone | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 9 | LEU A7052VAL A6859LEU A6883LEU A6924LEU A6852 | 1.50A | 19.03 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ALA D4324GLY C6875THR C6908ASP C6895LEU C6893 | 1.54A | 16.41 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ALA B4324GLY A6875THR A6908ASP A6895LEU A6893 | 1.48A | 16.41 | None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | ALA C6808GLY C7006CYH C7007LEU C6855THR C6854 | 1.76A | 19.03 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 9 | LEU A6883VAL A6882LEU A7042LEU B4298LEU A6848 | 1.55A | 19.03 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ALA D4324GLY C6875THR C6908ASP C6895LEU C6893 | 1.49A | 16.41 | None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | ALA A6808GLY A7006CYH A7007LEU A6855THR A6854 | 1.75A | 19.03 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 9 | LEU C6883VAL C6882LEU C7042LEU D4298LEU C6848 | 1.58A | 19.03 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 9 | LEU A6883VAL A6882LEU A7042LEU B4298LEU A6852 | 1.63A | 19.03 | None | ||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6w9q | 3C-LIKE PROTEINASEPEPTIDE, NSP9 FUSION (SARS-CoV-2) | 5 / 12 | VAL A 110ALA A 108LEU A 103LEU A -8LEU A 88 | 1.74A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | ALA A 60GLY A 85CYH A 92LEU A 93LEU A 88 | 1.78A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 77ALA A 112LEU A 93LEU A 109LEU A 43 | 1.45A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 9 | LEU A 83VAL A 82LEU A 127LEU A 43LEU A 122 | 1.53A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 77ALA A 112LEU A 93LEU A 109LEU A 43 | 1.53A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wen | NSP3 (SARS-CoV-2) | 5 / 9 | LEU A 83VAL A 82LEU A 127LEU A 43LEU A 122 | 1.51A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wen | NSP3 (SARS-CoV-2) | 5 / 9 | LEU A 93VAL A 95LEU A 126LEU A 122LEU A 109 | 1.79A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 281ALA A 316LEU A 297LEU A 313LEU A 247 | 1.49A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wey | NSP3 (SARS-CoV-2) | 5 / 9 | LEU A 287VAL A 286LEU A 331LEU A 247LEU A 326 | 1.54A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 355MET A 375LEU A 216THR A 217LEU A 344 | 1.30A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 9 | LEU B 122CYH A 32LEU A 13LEU A 56LEU A 60 | 1.58A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA E 311MET E 322LEU E 331GLY F 295LEU F 291 | 1.59A | CL F 401 ( 3.7A)NoneNoneNoneNone | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA A 311MET A 322LEU A 331GLY B 295LEU B 291 | 1.60A | CL B 401 ( 3.7A)NoneNoneNoneNone | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA E 305MET F 322LEU F 331GLY E 295LEU E 291 | 1.34A | CL E 401 ( 4.3A)NoneNoneNoneNone | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA D 311MET D 322LEU D 331GLY C 295LEU C 291 | 1.60A | CL C 401 ( 3.8A)NoneNoneNoneNone | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA B 305MET A 322LEU A 331GLY B 295LEU B 291 | 1.40A | CL B 401 ( 4.3A)NoneNoneNoneNone | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA A 264LYS A 266THR A 296GLY A 287LEU A 291 | 1.72A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA C 264LYS C 266THR C 296GLY C 287LEU C 291 | 1.74A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA D 305MET C 322LEU C 331GLY D 295LEU D 291 | 1.39A | CL D 401 ( 4.6A)NoneNoneNoneNone | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA C 305MET D 322LEU D 331GLY C 295LEU C 291 | 1.42A | CL C 401 ( 4.2A)NoneNoneNoneNone | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA F 305MET E 322LEU E 331GLY F 295LEU F 291 | 1.46A | CL F 401 ( 4.0A)NoneNoneNoneNone | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA A 305MET B 322LEU B 331GLY A 295LEU A 291 | 1.45A | CL A 401 ( 4.3A)NoneNoneNoneNone | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA C 311MET C 322LEU C 331GLY D 295LEU D 291 | 1.59A | CL D 401 ( 4.1A)NoneNoneNoneNone | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA F 311MET F 322LEU F 331GLY E 295LEU E 291 | 1.58A | CL E 401 ( 4.0A)NoneNoneNoneNone | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA C6877LEU C6883GLY D4323PHE C7048LEU C6887 | 1.74A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 9 | LEU C7052VAL C6859LEU C6883LEU C6924LEU C6852 | 1.49A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 9 | LEU C6883VAL C6882LEU C7042LEU D4298LEU C6848 | 1.57A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA D4324GLY C6875THR C6908ASP C6895LEU C6893 | 1.54A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | ALA A6808GLY A7006CYH A7007LEU A6855THR A6854 | 1.76A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA B4324GLY A6875THR A6908ASP A6895LEU A6893 | 1.48A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 9 | LEU C6834LYS C6844LEU C6848LEU D4298MET D4297 | 1.74A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 9 | LEU A6883VAL A6882LEU A7042LEU B4298LEU A6848 | 1.55A | NoneNoneNoneFMT B4403 (-4.7A)None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA B4324GLY A6875THR A6908ASP A6895LEU A6893 | 1.53A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA D4324GLY C6875THR C6908ASP C6895LEU C6893 | 1.50A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 9 | LEU A7052VAL A6859LEU A6883LEU A6924LEU A6852 | 1.51A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | ALA C6808GLY C7006CYH C7007LEU C6855THR C6854 | 1.77A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 9 | LEU C6883VAL C6882LEU C7042LEU D4298LEU C6848 | 1.58A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 9 | LEU C7052VAL C6859LEU C6883LEU C6924LEU C6852 | 1.50A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | ALA A6808GLY A7006CYH A7007LEU A6855THR A6854 | 1.74A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ALA B4324GLY A6875THR A6908ASP A6895LEU A6893 | 1.48A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 9 | LEU C6834LYS C6844LEU C6848LEU D4298MET D4297 | 1.75A | NoneFMT C7112 ( 4.7A)NoneNoneNone | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ALA D4324GLY C6875THR C6908ASP C6895LEU C6893 | 1.48A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ALA B4324GLY A6875THR A6908ASP A6895LEU A6893 | 1.52A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ALA D4324GLY C6875THR C6908ASP C6895LEU C6893 | 1.52A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 9 | LEU A7052VAL A6859LEU A6883LEU A6924LEU A6852 | 1.50A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 9 | LEU A6883VAL A6882LEU A7042LEU B4298LEU A6848 | 1.55A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | ALA C6808GLY C7006CYH C7007LEU C6855THR C6854 | 1.76A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ALA A 206LEU A 268LEU A 253GLY A 251PHE A 230 | 1.67A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 148LEU A 89LEU A 32GLY A 15LEU A 27 | 1.73A | NoneNoneNoneNoneU5G A 401 ( 4.0A) | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 9 | LEU A 87VAL A 86LEU A 32LEU A 30LEU A 89 | 1.71A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 202THR A 292GLY A 251LEU A 253PHE A 3 | 1.72A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 146CYH A 38LEU A 87LEU A 27THR A 26 | 1.67A | NoneNoneNoneU5G A 401 ( 4.0A)None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 9 | LEU A 32VAL A 35LYS A 88LEU A 87LEU A 30 | 1.79A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 9 | LEU A 75VAL A 68LEU A 27MET A 17LEU A 87 | 1.64A | NoneNoneU5G A 401 ( 4.0A)NoneNone | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL D 77ALA D 112LEU D 93LEU D 109LEU D 43 | 1.55A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | LEU B 83VAL B 82LEU B 127LEU B 43LEU B 122 | 1.57A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | LEU A 83VAL A 82LEU A 127LEU A 43LEU A 122 | 1.60A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 77ALA A 112LEU A 93LEU A 109LEU A 43 | 1.50A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL B 77ALA B 112LEU B 93LEU B 109LEU B 43 | 1.52A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL C 77ALA C 112LEU C 93LEU C 109LEU C 43 | 1.52A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | LEU C 83VAL C 82LEU C 127LEU C 43LEU C 122 | 1.56A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | LEU D 83VAL D 82LEU D 127LEU D 43LEU D 122 | 1.54A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 9 | LEU A6883VAL A6882LEU A7042LEU B4298LEU A6848 | 1.55A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 9 | LEU A6883VAL A6882LEU A7042LEU B4298LEU A6852 | 1.62A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA B4324GLY A6875THR A6908ASP A6895LEU A6893 | 1.47A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | ALA A6808GLY A7006CYH A7007LEU A6855THR A6854 | 1.71A | NoneNone8NK A7103 ( 3.7A)8NK A7103 (-3.6A)None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 9 | LEU A7052VAL A6859LEU A6883LEU A6924LEU A6852 | 1.61A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA B4324GLY A6875THR A6908ASP A6895LEU A6893 | 1.51A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA A6877LEU A6883GLY B4323PHE A7048LEU A6887 | 1.72A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | VAL C 66ALA C 65MET C 52LEU C 60LEU D 95 | 1.76A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 9 | LEU B 122CYH A 32LEU A 13LEU A 56LEU A 60 | 1.57A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 9 | LEU D 122CYH C 32LEU C 13LEU C 56LEU C 60 | 1.60A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 148LEU A 89LEU A 32GLY A 15LEU A 27 | 1.70A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ALA A 129LEU A 282THR A 292ASP A 295PHE A 294 | 1.46A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 29CYH A 38LEU A 87LEU A 27THR A 25 | 1.75A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 146CYH A 38LEU A 87LEU A 27THR A 26 | 1.75A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 9 | LEU A 287VAL A 204LEU A 242LEU A 271LEU A 250 | 1.79A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 204THR A 199GLY A 275LEU A 272LEU A 242 | 1.67A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 9 | LEU A 75VAL A 68LEU A 27MET A 17LEU A 87 | 1.75A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | LEU B 75VAL B 68LEU B 27MET B 17LEU B 87 | 1.61A | 22.55 | None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ALA B 129LEU B 282THR B 292ASP B 295PHE B 294 | 1.39A | 22.55 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6y84 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 86MET A 130LEU A 27GLY A 29PHE A 112 | 1.33A | 21.17 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | LEU A 32VAL A 35LYS A 88LEU A 87LEU A 30 | 1.76A | 22.98 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 204THR A 199GLY A 275LEU A 272LEU A 242 | 1.66A | 20.78 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 86MET A 130LEU A 27GLY A 29PHE A 112 | 1.37A | 20.78 | None | ||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ALA A 129LEU A 282THR A 292ASP A 295PHE A 294 | 1.44A | 22.98 | NoneNoneNoneDMS A 403 ( 4.3A)None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 202THR A 292GLY A 251LEU A 253PHE A 3 | 1.76A | 20.78 | None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | LEU A 75VAL A 68LEU A 27MET A 17LEU A 87 | 1.65A | 22.98 | None | ||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 148LEU A 89LEU A 32GLY A 15LEU A 27 | 1.68A | 20.78 | NoneNoneNoneDMS A 406 (-3.7A)None | ||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 9 | LEU D 122CYH C 32LEU C 13LEU C 56LEU C 60 | 1.62A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yla | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | LEU E 387THR E 385GLY H 98THR H 31PHE E 377 | 1.66A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yla | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | MET H 2THR E 385LEU E 387GLY E 431THR H 31 | 1.69A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yla | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | LEU A 387THR A 385GLY B 98THR B 31PHE A 377 | 1.74A | DMS A 905 ( 4.2A)NoneNoneNoneNone | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ym0 | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | LEU E 387THR E 385GLY H 98THR H 31PHE E 377 | 1.76A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ym0 | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | MET H 2THR E 385LEU E 387GLY E 431THR H 31 | 1.72A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 148LEU A 89LEU A 32GLY A 15LEU A 27 | 1.72A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 202THR A 292GLY A 251LEU A 253PHE A 3 | 1.73A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | LEU A 75VAL A 68LEU A 27MET A 17LEU A 87 | 1.69A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 29CYH A 38LEU A 87LEU A 27THR A 25 | 1.69A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 146CYH A 38LEU A 87LEU A 27THR A 26 | 1.72A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 86MET A 130LEU A 27GLY A 29PHE A 112 | 1.39A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 204THR A 199GLY A 275LEU A 272LEU A 242 | 1.64A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | LEU E 387THR E 385GLY H 98THR H 31PHE E 377 | 1.66A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | MET B 2THR A 385LEU A 387GLY A 431THR B 31 | 1.69A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | LEU A 387THR A 385GLY B 98THR B 31PHE A 377 | 1.66A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | MET H 2THR E 385LEU E 387GLY E 431THR H 31 | 1.69A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ALA A 129LEU A 282THR A 292ASP A 295PHE A 294 | 1.51A | NoneNoneNone CL A 406 (-3.4A)None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 148LEU A 89LEU A 32GLY A 15LEU A 27 | 1.70A | NoneNoneNoneNonePK8 A 401 ( 3.6A) | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | LEU A 75VAL A 68LEU A 27MET A 17LEU A 87 | 1.74A | NoneNonePK8 A 401 ( 3.6A)NoneNone | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 202THR A 292GLY A 251LEU A 253PHE A 3 | 1.71A | PEG A 405 (-4.1A)NoneNoneNoneNone | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 204THR A 199GLY A 275LEU A 272LEU A 242 | 1.66A | NonePEG A 404 (-3.0A)PEG A 404 ( 4.8A)PEG A 404 (-3.4A)None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 86MET A 130LEU A 27GLY A 29PHE A 112 | 1.40A | NoneNonePK8 A 401 ( 3.6A)NoneNone | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU A 83VAL A 82LEU A 127LEU A 43LEU A 122 | 1.56A | NoneNoneEDO A 202 ( 4.8A)NoneNone | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU D 83VAL D 82LEU D 127LEU D 43LEU D 122 | 1.56A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL C 77ALA C 112LEU C 93LEU C 109LEU C 43 | 1.56A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 77ALA B 112LEU B 93LEU B 109LEU B 43 | 1.54A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL D 77ALA D 112LEU D 93LEU D 109LEU D 43 | 1.55A | NoneNoneNoneEDO D 204 ( 4.5A)None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL A 77ALA A 112LEU A 93LEU A 109LEU A 43 | 1.58A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU C 83VAL C 82LEU C 127LEU C 43LEU C 122 | 1.55A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU B 83VAL B 82LEU B 127LEU B 43LEU B 122 | 1.54A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU E 83VAL E 82LEU E 127LEU E 43LEU E 122 | 1.52A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU E 83VAL E 82LEU E 127LEU E 43LEU E 122 | 1.52A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA C 60LEU C 88THR C 57GLY D 48ASP D 157 | 1.69A | EDO D 204 ( 4.8A)NoneNoneEDO D 204 ( 3.4A)None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU B 83VAL B 82LEU B 127LEU B 43LEU B 122 | 1.54A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU A 83VAL A 82LEU A 127LEU A 43LEU A 122 | 1.55A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU D 83VAL D 82LEU D 127LEU D 43LEU D 122 | 1.57A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU C 83VAL C 82LEU C 127LEU C 43LEU C 122 | 1.55A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL E 77ALA E 112LEU E 93LEU E 109LEU E 43 | 1.57A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 77ALA B 112LEU B 93LEU B 109LEU B 43 | 1.56A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL D 77ALA D 112LEU D 93LEU D 109LEU D 43 | 1.59A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL C 77ALA C 112LEU C 93LEU C 109LEU C 43 | 1.57A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL A 77ALA A 112LEU A 93LEU A 109LEU A 43 | 1.58A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL C 77ALA C 112LEU C 93LEU C 109LEU C 43 | 1.57A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 49ALA B 38LEU B 126GLY B 46LEU B 160 | 1.79A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU A 83VAL A 82LEU A 127LEU A 43LEU A 122 | 1.54A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU B 83VAL B 82LEU B 127LEU B 43LEU B 122 | 1.54A | NoneEDO B 203 ( 4.6A)NoneNoneNone | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU C 83VAL C 82LEU C 127LEU C 43LEU C 122 | 1.55A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL A 77ALA A 112LEU A 93LEU A 109LEU A 43 | 1.57A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL A 49ALA A 38LEU A 126GLY A 46LEU A 160 | 1.78A | NoneMES A 201 (-3.5A)NoneMES A 201 ( 4.9A)None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 148LEU A 89LEU A 32GLY A 15LEU A 27 | 1.70A | NoneNoneNoneNonePJE C 5 (-4.2A) | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 202THR A 292GLY A 251LEU A 253PHE A 3 | 1.71A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 9 | LEU A 87VAL A 86LEU A 32LEU A 30LEU A 89 | 1.80A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 9 | LEU A 75VAL A 68LEU A 27MET A 17LEU A 87 | 1.60A | NoneNonePJE C 5 (-4.2A)NoneNone | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | ALA A 129LEU A 282THR A 292ASP A 295PHE A 294 | 1.50A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | ALA A 206LEU A 268LEU A 253GLY A 251PHE A 230 | 1.67A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 9 | LEU A 245LEU A 212LEU A 178LEU A 186LEU A 142 | 1.76A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7btf | NSP7 (SARS-CoV-2) | 5 / 12 | VAL C 66ALA C 65LEU C 60LEU C 20LEU C 56 | 1.72A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7btf | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | VAL A 330ALA A 383LEU B 122LEU B 103LEU A 271 | 1.70A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 9 | CYH A 464LEU A 316LEU A 245LEU A 460LEU A 241 | 1.58A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | VAL A 844LEU A 883GLY A 852LEU A 891PHE A 422 | 1.61A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | VAL A 860LEU A 885GLY A 852LEU A 891PHE A 422 | 1.73A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | VAL A 476MET A 629LEU A 630LEU A 638LEU A 308 | 1.65A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7btf | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | ALA B 86LEU A 371THR B 84GLY A 510LEU A 514 | 1.72A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 9 | LEU A 207LEU A 247LEU A 131LEU A 240LEU A 178 | 1.65A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7btf | NSP7NSP8 (SARS-CoV-2) | 5 / 9 | LEU D 122CYH C 32LEU C 13LEU C 56LEU C 60 | 1.57A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | VAL A 174ALA A 176LEU A 178THR A 248LEU A 142 | 1.60A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7btf | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | VAL C 66MET C 52LEU C 56LEU C 20LEU D 91 | 1.69A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | ALA A 206LEU A 268LEU A 253GLY A 251PHE A 230 | 1.69A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 204THR A 199GLY A 275LEU A 272LEU A 242 | 1.70A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 148LEU A 89LEU A 32GLY A 15LEU A 27 | 1.72A | NoneNoneNoneDMS A 403 (-3.7A)None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 9 | LEU A 75VAL A 68LEU A 27MET A 17LEU A 87 | 1.67A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 296ALA A 210LEU A 205GLY A 302THR A 257 | 1.76A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 296ALA A 210LEU A 282GLY A 2THR A 304 | 1.73A | NoneNoneDMS A 404 (-4.9A)DMS A 404 (-3.3A)None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 9 | LEU A 87VAL A 86LEU A 32LEU A 30LEU A 89 | 1.78A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | VAL A 476MET A 629LEU A 630LEU A 638LEU A 308 | 1.63A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | VAL A 128LEU A 178THR A 248LEU A 186LEU A 212 | 1.74A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | VAL A 342LEU A 366LEU A 361PHE B 92LEU B 91 | 1.64A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | VAL A 405ALA A 406GLY A 446ASP A 390LEU A 388 | 1.75A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ALA A 176THR A 248CYH A 152ASP A 153LEU A 146 | 1.76A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | VAL B 115LEU A 270GLY A 345PHE A 396LEU B 122 | 1.79A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | ALA A 382LEU B 98GLY A 671LEU A 401LEU B 91 | 1.52A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | VAL A 342LEU A 366LEU A 361PHE B 92LEU B 91 | 1.55A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | VAL A 405ALA A 406GLY A 446ASP A 390LEU A 388 | 1.76A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | ALA B 86THR B 89LEU A 527LEU A 371PHE A 340 | 1.75A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214LEU A 119ARG A 118LEU A 212ASP A 126 | 1.45A | None | |||
![]() | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | ALA A 382LEU A 387LEU B 103THR B 124LEU A 270 | 1.72A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 9 | LEU A 207LEU A 247LEU A 131LEU A 240LEU A 178 | 1.67A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | VAL A 174ALA A 176LEU A 178THR A 248LEU A 142 | 1.60A | None | |||
![]() | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 9 | CYH A 464LEU A 316LEU A 245LEU A 460LEU A 241 | 1.64A | None | |||
![]() | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 146THR A 148GLY A 214LEU A 212LEU A 142 | 1.79A | None | |||
![]() | 1XKK_A_FMMA91_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214LEU A 119ARG A 118ASP A 208PHE A 45 | 1.51A | None |